What is PACELINE?
For over three decades, PACELINE has functioned as a critical infrastructure provider for the medical device industry. The company specializes in the engineering and fabrication of high-quality products and bespoke solutions tailored for orthopedic, prosthetic, orthotic, and surgical applications. By serving as a trusted resource for medical manufacturers and clinical practitioners, PACELINE occupies a vital niche in the healthcare ecosystem, bridging the gap between raw material innovation and patient-centric medical outcomes. Its market position is defined by a commitment to precision, reliability, and deep-seated technical proficiency in complex medical hardware.
How much funding has PACELINE raised?
PACELINE has raised a total of $848K across 2 funding rounds:
Debt
$350K
Debt
$498K
Debt (2020): $350K with participation from PPP
Debt (2021): $498K led by PPP
Key Investors in PACELINE
PPP
Public-Private Partnership
What's next for PACELINE?
With the successful acquisition of this major enterprise-level funding, PACELINE is well-positioned to accelerate its strategic initiatives. The capital will likely be deployed to enhance manufacturing throughput, expand its portfolio of custom medical solutions, and further integrate its supply chain capabilities to support the increasing complexity of modern surgical and prosthetic requirements. As the healthcare sector continues to prioritize high-performance, durable medical components, PACELINE's focus on scaling its production capacity and refining its technical offerings will be instrumental in maintaining its competitive advantage. The firm remains focused on long-term value creation, ensuring that its infrastructure remains robust enough to support the next generation of medical device advancements.
See full PACELINE company page
